Notably, higher expression of SIGLEC15 mRNA in the bone marrow was associated with longer event-free survival in a cohort of 98 children with B-ALL enriched for those with early relapse (Supplementary Fig. S1B). The gene discussed is SIGLEC15; the disease is precursor B-cell acute lymphoblastic leukemia.